These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19593318)

  • 21. Vitamin D and the cardiovascular system.
    Artaza JN; Mehrotra R; Norris KC
    Clin J Am Soc Nephrol; 2009 Sep; 4(9):1515-22. PubMed ID: 19696220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trajectories of entering the metabolic syndrome: the framingham heart study.
    Franco OH; Massaro JM; Civil J; Cobain MR; O'Malley B; D'Agostino RB
    Circulation; 2009 Nov; 120(20):1943-50. PubMed ID: 19884471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein-associated phospholipase A2: an independent predictor of cardiovascular risk and a novel target for immunomodulation therapy.
    Khakpour H; Frishman WH
    Cardiol Rev; 2009; 17(5):222-9. PubMed ID: 19690473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The emerging risk factors for cardiovascular disease: a review of the epidemiologic evidence for lipoprotein(a), homocysteine, and fibrinogen.
    Catena C; Cavarape A; Dotto L; Colussi G; Novehllo M; De Marchi S; Sechi LA
    Adv Clin Path; 2003 Jan; 7(1):3-11. PubMed ID: 19774732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of the individual absolute cardiovascular risk. A mathematical equation and/or arterial measurement?].
    Blacher J; Bortolotto L; Iaria P; London G; Safar M
    Arch Mal Coeur Vaiss; 1999 Jul; 92(7):887-91. PubMed ID: 10443309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Global risk and objectives in cardiovascular diseases].
    Güleç S
    Turk Kardiyol Dern Ars; 2009 Mar; 37 Suppl 2():1-10. PubMed ID: 19404044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Women and heart disease: missed opportunities.
    Banks AD
    J Midwifery Womens Health; 2008; 53(5):430-9. PubMed ID: 18761296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic examination of the updated Framingham heart study general cardiovascular risk profile.
    Marma AK; Lloyd-Jones DM
    Circulation; 2009 Aug; 120(5):384-90. PubMed ID: 19620502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Old and new scoring systems for assessing cardiovascular risks: problems with the validity, the precision and the homogenicity of the risk categories].
    Smulders YM; Spijkerman AM; Kostense PJ; Bouter LM; Stehouwer CD
    Ned Tijdschr Geneeskd; 2004 Dec; 148(50):2480-4. PubMed ID: 15638194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular risk in patients with peripheral vascular diseases.
    Stoica A; Ginghină C
    Rom J Intern Med; 2008; 46(4):275-83. PubMed ID: 19480293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biobanks and the search for predictive biomarkers of local and systemic outcome in atherosclerotic disease.
    Hurks R; Peeters W; Derksen WJ; Hellings WE; Hoefer IE; Moll FL; de Kleijn DP; Pasterkamp G
    Thromb Haemost; 2009 Jan; 101(1):48-54. PubMed ID: 19132188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The metabolic syndrome: definitions, prevalence and management.
    Levesque J; Lamarche B
    J Nutrigenet Nutrigenomics; 2008; 1(3):100-8. PubMed ID: 19776619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Why and how to measure cardiovascular risk?].
    Krummel T; Dervaux T; Parvès-Braun L; Hannedouche T
    Rev Prat; 2004 Mar; 54(6):615-7, 619, 621-25. PubMed ID: 15222612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving outcomes in high-risk populations using REACH: an inpatient cardiac risk reduction program.
    Patel PV; Gilski D; Morrison J
    Crit Pathw Cardiol; 2009 Sep; 8(3):112-8. PubMed ID: 19726930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Panoptic total cardiovascular risk prediction using all predictors versus optimized risk assessment using variable subsets.
    Horne BD; Knight S; May HT
    Future Cardiol; 2012 Sep; 8(5):765-78. PubMed ID: 23013127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A convenient tool to profile patients for generalized cardiovascular disease risk in primary care.
    Wickramasinghe SR; DeFilippis AP; Lloyd-Jones DM; Blumenthal RS
    Am J Cardiol; 2009 Apr; 103(8):1174-7. PubMed ID: 19361610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The contribution of familial and heritable risks in heart failure.
    Abdel-Qadir HM; Lee DS
    Curr Opin Cardiol; 2007 May; 22(3):214-9. PubMed ID: 17413278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cardiovascular risk as assessed by traditional risk factors].
    Chironi G
    Rev Prat; 2012 Jun; 62(6):776-80. PubMed ID: 22838268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative T-wave alternans: could an index adjusting for T-wave amplitude be even better?
    Madias JE
    J Cardiovasc Electrophysiol; 2009 Jun; 20(6):E65; author reply E64. PubMed ID: 19470034
    [No Abstract]   [Full Text] [Related]  

  • 40. Periodontal treatment: potential to reduce cardiovascular morbidity and/or mortality.
    Yao Z; Yang J; Pan L; Chen Z
    Med Hypotheses; 2009 Jul; 73(1):33-5. PubMed ID: 19329257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.